Adverse cutaneous drug eruptions

The skin is one of the most frequently involved organs in adverse drug reactions. Occurring with an incidence of 1-5% for certain types of drugs, cutaneous drug eruptions are mostly benign in nature, and comprise the maculopapular type of eruption and urticaria. However, about one third of them requ...

Full description

Main Author: French, Lars E.
Format: eBook
Language:English
Published: Basel Karger 2012, 2012
Series:Chemical immunology and allergy
Subjects:
Online Access:
Collection: Karger eBooks Collection 1997-2013 - Collection details see MPG.ReNa
LEADER 01838nmm a2200253 u 4500
001 EB001265536
003 EBX01000000000000000880120
005 00000000000000.0
007 cr|||||||||||||||||||||
008 161024 ||| eng
020 |a 9783805599702 
020 |a 9783805599719 
100 1 |a French, Lars E. 
245 0 0 |a Adverse cutaneous drug eruptions  |h Elektronische Ressource  |c vol. ed. Lars E. French .. 
260 |a Basel  |b Karger  |c 2012, 2012 
300 |a XIV, 240 S. 
653 |a (DE-588)4303107-9 / Arzneimittelexanthem / gnd 
041 0 7 |a eng  |2 ISO 639-2 
989 |b ZDB-1-KEB  |a Karger eBooks Collection 1997-2013 
490 0 |a Chemical immunology and allergy 
856 |u http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=256747  |x Verlag  |3 Volltext 
082 0 |a 610 
520 |a The skin is one of the most frequently involved organs in adverse drug reactions. Occurring with an incidence of 1-5% for certain types of drugs, cutaneous drug eruptions are mostly benign in nature, and comprise the maculopapular type of eruption and urticaria. However, about one third of them require hospital treatment, leading to a considerable burden for the health care system.In this book, a selected group of experts provide an up-to-date, condensed and clinically relevant overview of the field of cutaneous drug eruptions, ranging from epidemiology and genetic predisposition to available therapeutic measures, including rapid drug desensitization. Reflecting the great progress made in recent years in this field, this publication will be a useful tool for a better understanding, diagnosis and management of cutaneous drug eruptions, not only for general physicians, dermatologists and clinical allergologists, but also for nurses and scientists